"Benitec is committed to completing the collection of trial data and monitoring patients through the required long- term safety follow-up period. Final data supporting the primary and secondary endpoints of the study will be reported in CYQ4 2016 when the study is completed "
If the viral load was poor, why continue and how can they not tell us, as it would merit a material event...
Ann: UPDATE ON HCV CLINICAL TRIAL, page-55
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)